The Academy of Oncology Nurse & Patient Navigators (AONN+) Joins... Posted By: Anonymous | Posted On: Sep 17,2021 11:00 am | View: 47
AONN+ joins numerous patient care organizations in writing to Administrator Brooks-LaSure on exercising caution in making changes to Medicare & Medicaid Services payment policies during the... read more ...
New publication in European Urology demonstrates value of... Posted By: Anonymous | Posted On: Sep 16,2021 23:00 pm | View: 22
Results from the study utilizing Predicine’s liquid biopsy assay for monitoring patients with metastatic castration-resistant prostate cancer treated with PD-L1 inhibitor and SABR are now published in... read more ...
SITC Debuts Clinical Practice Guidelines Mobile App Focused on... Posted By: Anonymous | Posted On: Sep 16,2021 23:00 pm | View: 37
The Society for Immunotherapy of Cancer (SITC) has launched a new mobile app. The SITC Clinical Practice Guidelines (CPG) Mobile App is the first and only free open-access resource offering easy... read more ...
SITC and AACR Outline Future Directions for Investigating... Posted By: Anonymous | Posted On: Sep 15,2021 11:00 am | View: 38
The Society for Immunotherapy of Cancer (SITC) and the American Association for Cancer Research (AACR) have partnered to define recommendations for advancing the understanding of immune-related... read more ...
Crush Challenge Is Back in 2021 Posted By: Anonymous | Posted On: Sep 14,2021 23:00 pm | View: 44
The 7th year of the ultimate Napa Valley food, wine, and cycling lifestyle event returns on October 9 read more ...
iThera Medical leads €1.9m research project to advance optoacoustic... Posted By: Anonymous | Posted On: Sep 13,2021 23:00 pm | View: 23
Medical device company iThera Medical announces the kickoff of the Bavarian state-funded technology innovation project DeepOPUS. The project aims to augment the company’s proprietary optoacoustic... read more ...
Phase III POSEIDON Trial Shows Positive Results for Patients Taking... Posted By: Anonymous | Posted On: Sep 11,2021 23:00 pm | View: 59
Study presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer; Patients with metastatic non-small cell lung cancer (mNSCLC) who received a combined regimen... read more ...
IMpower010 Shows Significantly Improved Disease-free Survival for... Posted By: Anonymous | Posted On: Sep 11,2021 23:00 pm | View: 39
The Phase III IMpower010 trial evaluating atezolizumab vs best supportive care after surgical resection and adjuvant chemotherapy met its primary endpoint showing significant disease-free survival... read more ...
Disclaimer: Issuers of the submissions/postings are solely responsible for the content of their submissions. Doctorsoutlook.com can't be held liable for the contents of these submissions. In case any submission damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.
